• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质:经认证的执业营养师的诊断标准和治疗方法概述。

Cancer cachexia: an overview of diagnostic criteria and therapeutic approaches for the accredited practicing dietitian.

机构信息

Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia.

Department of Nutrition and Dietetics, Mater Hospital, South Brisbane, QLD, Australia.

出版信息

J Hum Nutr Diet. 2021 Feb;34(1):243-254. doi: 10.1111/jhn.12811. Epub 2020 Oct 10.

DOI:10.1111/jhn.12811
Abstract

BACKGROUND

Cancer cachexia (CC) is a multifactorial syndrome characterised by ongoing skeletal muscle loss that leads to progressive functional impairment driven by reduced food intake and abnormal metabolism. Despite the traditional use of non-volitional weight loss as the primary marker of CC, there is no consensus on how to diagnose and manage CC.

METHODS

The aim of this narrative review was to describe and discuss diagnostic criteria and therapeutic approaches for the accredited practicing dietitian with respect to identifying and managing CC.

RESULTS

Available diagnostic criteria for cachexia include the cancer-specific (Fearon and Cachexia Score) and general criteria (Evans and Global Leadership Initiative on Malnutrition). These include phenotypic criteria [weight loss, body mass index, (objective) muscle mass assessments, quality of life] and aetiological criteria (disease burden, inflammation, energy expenditure, anorexia and inadequate food intake) and can be incorporated into the nutrition care process (NCP). This informs the nutrition diagnosis of 'chronic disease- or condition-related malnutrition (undernutrition) as related to increased nutrient needs, anorexia or diminished intake due to CC'. Optimal nutrition care and management of CC is multidisciplinary, corrects for increased energy expenditure (via immunonutrition/eicosapentaenoic acid), suboptimal protein/energy intake and poor nutrition quality of life, and includes a physical exercise intervention. Monitoring of intervention efficacy should focus on maintaining or slowing the loss of muscle mass, with weight change as an alternative gross indicator.

CONCLUSIONS

Dietitians and the NCP can play an essential role with respect to identifying and managing CC, focusing on aspects of nutrition screening, assessment and intervention.

摘要

背景

癌症恶病质(CC)是一种多因素综合征,其特征为持续的骨骼肌丢失,导致进行性功能障碍,其原因是食物摄入减少和代谢异常。尽管非自愿性体重减轻一直被用作 CC 的主要标志物,但在如何诊断和管理 CC 方面尚未达成共识。

方法

本叙述性综述的目的是描述和讨论经过认证的执业营养师在识别和管理 CC 方面的诊断标准和治疗方法。

结果

现有的恶病质诊断标准包括癌症特异性(Fearon 和恶病质评分)和一般标准(Evans 和全球营养不良领导倡议)。这些标准包括表型标准[体重减轻、体重指数、(客观)肌肉质量评估、生活质量]和病因标准(疾病负担、炎症、能量消耗、厌食和摄入不足),并可纳入营养护理过程(NCP)。这为“与疾病相关的营养不良(营养不足),由于 CC 导致营养需求增加、厌食或摄入不足”提供了营养诊断。CC 的最佳营养护理和管理是多学科的,纠正了能量消耗增加(通过免疫营养/二十碳五烯酸)、蛋白质/能量摄入不足和营养质量差,并包括身体运动干预。干预效果的监测应侧重于维持或减缓肌肉量的损失,体重变化是替代的总指标。

结论

营养师和 NCP 可以在识别和管理 CC 方面发挥重要作用,重点关注营养筛查、评估和干预的方面。

相似文献

1
Cancer cachexia: an overview of diagnostic criteria and therapeutic approaches for the accredited practicing dietitian.癌症恶病质:经认证的执业营养师的诊断标准和治疗方法概述。
J Hum Nutr Diet. 2021 Feb;34(1):243-254. doi: 10.1111/jhn.12811. Epub 2020 Oct 10.
2
Definition and classification of cancer cachexia: an international consensus.癌症恶病质的定义和分类:国际共识。
Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4.
3
Measuring cachexia-diagnostic criteria.测量恶病质诊断标准。
Ann Palliat Med. 2019 Jan;8(1):24-32. doi: 10.21037/apm.2018.08.07. Epub 2018 Sep 7.
4
Nutritional support in multimodal therapy for cancer cachexia.癌症恶病质多模式治疗中的营养支持
Support Care Cancer. 2008 May;16(5):447-51. doi: 10.1007/s00520-007-0388-7. Epub 2008 Jan 15.
5
Cancer cachexia: a multifactoral disease that needs a multimodal approach.癌症恶病质:一种多因素疾病,需要多模式治疗方法。
Curr Opin Gastroenterol. 2020 Mar;36(2):141-146. doi: 10.1097/MOG.0000000000000603.
6
Cancer Cachexia: Cause, Diagnosis, and Treatment.癌症恶病质:病因、诊断与治疗。
Nutr Clin Pract. 2017 Oct;32(5):599-606. doi: 10.1177/0884533617722986. Epub 2017 Aug 21.
7
SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).SEOM 癌症恶病质厌食症综合征临床指南(2023 年)。
Clin Transl Oncol. 2024 Nov;26(11):2866-2876. doi: 10.1007/s12094-024-03502-8. Epub 2024 Jun 1.
8
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community.GLIM 营养不良诊断标准:全球临床营养界共识报告。
JPEN J Parenter Enteral Nutr. 2019 Jan;43(1):32-40. doi: 10.1002/jpen.1440. Epub 2018 Sep 2.
9
Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later.癌症相关性营养不良、恶病质和肌肉减少症:40 年后医院衣橱里的“骷髅”。
Proc Nutr Soc. 2016 May;75(2):199-211. doi: 10.1017/S002966511500419X. Epub 2016 Jan 20.
10
Cachexia in patients with oesophageal cancer.食管癌患者的恶病质。
Nat Rev Clin Oncol. 2016 Mar;13(3):185-98. doi: 10.1038/nrclinonc.2015.200. Epub 2015 Nov 17.

引用本文的文献

1
Multimodal interventions for cachexia management.用于恶病质管理的多模式干预措施。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015749. doi: 10.1002/14651858.CD015749.pub2.
2
The Importance of Nutrition in Cancer Care: A Narrative Review.营养在癌症治疗中的重要性:一篇叙述性综述。
Curr Nutr Rep. 2024 Dec;13(4):950-965. doi: 10.1007/s13668-024-00578-0. Epub 2024 Sep 15.
3
Factors associated with multimodal care practices for cancer cachexia among registered dietitians.与注册营养师对癌症恶病质进行多模式治疗相关的因素。
Support Care Cancer. 2024 Mar 6;32(4):213. doi: 10.1007/s00520-024-08417-2.
4
Prognostic Significance of the Cachexia Index in Patients with Non-Small-Cell Lung Cancer and Brain Metastases after Stereotactic Radiotherapy.恶病质指数在非小细胞肺癌脑转移患者立体定向放射治疗后的预后意义
Clin Med Insights Oncol. 2024 Mar 3;18:11795549231222362. doi: 10.1177/11795549231222362. eCollection 2024.
5
To Be Frail or Not to Be Frail: This Is the Question-A Critical Narrative Review of Frailty.衰弱与否:这是个问题——对衰弱的批判性叙述性综述
J Clin Med. 2024 Jan 26;13(3):721. doi: 10.3390/jcm13030721.
6
Dietary Intake Is Not Associated with Body Composition nor with Biochemical Tests but with Psychological Status of Cancer Patients Receiving Chemotherapy.饮食摄入与癌症患者化疗期间的身体成分和生化测试无关,但与心理状态有关。
Nutrients. 2023 Dec 13;15(24):5087. doi: 10.3390/nu15245087.
7
The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors.血管内皮生长因子受体酪氨酸激酶抑制剂治疗期间癌症相关性厌食症的发生率及管理
Cancer Manag Res. 2023 Sep 22;15:1033-1046. doi: 10.2147/CMAR.S417238. eCollection 2023.
8
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.首次肿瘤内科就诊时营养状况对临床结局的影响:NUTRIONCO研究
Cancers (Basel). 2023 Jun 15;15(12):3206. doi: 10.3390/cancers15123206.
9
Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study.恶病质指数对结直肠癌患者的预后价值:一项回顾性研究。
Front Oncol. 2022 Sep 23;12:984459. doi: 10.3389/fonc.2022.984459. eCollection 2022.
10
Cachexia Index as a Prognostic Indicator in Patients with Gastric Cancer: A Retrospective Study.恶病质指数作为胃癌患者的预后指标:一项回顾性研究。
Cancers (Basel). 2022 Sep 10;14(18):4400. doi: 10.3390/cancers14184400.